Latest Findings From The Breast Cancer Cohort In Summit - A Phase 2 'Basket' Trial Of Neratinib Plus Trastuzumab Plus Fulvestrant For Her2-Mutant, Hormone Receptor-Positive, Metastatic Breast Cancer

CANCER RESEARCH(2021)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要